These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 38505173)

  • 1. Comprehensive analysis of the Cullin family of genes reveals that CUL7 and CUL9 are the significant prognostic biomarkers in colorectal cancer.
    Zhang L; Hua M; Wang Y; Sun A
    Am J Transl Res; 2024; 16(5):1907-1924. PubMed ID: 38883340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic approach introduced some immune system targets in rectal cancer by considering cell-free DNA methylation in response to radiochemotherapy.
    Bagheri-Hosseinabadi Z; Eshkevari SMS; Khalighfard S; Alizadeh AM; Khori V; Amiriani T; Poorkhani A; Sadani S; Esmati E; Lashgari M; Mahmoodi M; Hajizadeh MR
    Cytokine; 2024 Jun; 181():156666. PubMed ID: 38906038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis to identify novel potential biomarkers as drug targets in colorectal cancer therapy: an integrated bioinformatics analysis.
    Gatasheh MK; Natarajan SR; Krishnamoorthy R; Alsulami TS; Rajagopal P; Palanisamy CP; Veeraraghavan VP; Jayaraman S
    Mol Cell Oncol; 2024; 11(1):2326699. PubMed ID: 38505173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
    Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
    Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
    Hammad A; Elshaer M; Tang X
    Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
    Chen J; Wang Z; Shen X; Cui X; Guo Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and analysis of the molecular targets of statins in colorectal cancer.
    Firouzjaei AA; Mahmoudi A; Almahmeed W; Teng Y; Kesharwani P; Sahebkar A
    Pathol Res Pract; 2024 Apr; 256():155258. PubMed ID: 38522123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of four novel prognosis biomarkers and potential therapeutic drugs for human colorectal cancer by bioinformatics analysis.
    Sun Z; Liu C; Cheng SY
    J Biomed Res; 2020 Oct; 35(1):21-35. PubMed ID: 33361643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Analysis of Role of Cyclin-Dependent Kinases Family Members in Colorectal Cancer.
    Guan L; Tang Y; Li G; Qin Z; Li S
    Front Oncol; 2022; 12():921710. PubMed ID: 35814446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N
    Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-Binding Protein COL14A1, TNS1, NUSAP1 and YWHAE Are Valid Biomarkers to Predict Peritoneal Metastasis in Gastric Cancer.
    Jiang Y; Chen F; Ren X; Yang Y; Luo J; Yuan J; Yuan J; Tong Q
    Front Oncol; 2022; 12():830688. PubMed ID: 35515139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated pan-cancer of AURKA expression and drug sensitivity analysis reveals increased expression of AURKA is responsible for drug resistance.
    Miralaei N; Majd A; Ghaedi K; Peymani M; Safaei M
    Cancer Med; 2021 Sep; 10(18):6428-6441. PubMed ID: 34337875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis.
    Sawicki T; Ruszkowska M; Danielewicz A; Niedźwiedzka E; Arłukowicz T; Przybyłowicz KE
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922197
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.